Genticel's IPO

Genticel raised a round of funding on April 08, 2014. Investors include Public.

Genticel, formerly BT Pharma, develops therapeutic solutions for women already infected by the human papillomavirus (HPV) before high grade lesions or cervical cancer occur. Besides ProCervix, its oth…

Articles about Genticel's IPO: